TREA

79336403 - CUVUE ORPHALAN

Follow

Information

  • Trademark
  • 79336403
  • Serial Number
    79336403
  • Registration Number
    6927021
  • Filing Date
    November 30, 2021
    2 years ago
  • Registration Date
    December 20, 2022
    a year ago
  • Transaction Date
    April 25, 2023
    a year ago
  • Status Date
    December 20, 2022
    a year ago
  • Published for Opposition Date
    October 04, 2022
    2 years ago
  • Location Date
    December 20, 2022
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GALANTE, JOSHUA MICHAE
  • Attorney Docket Number
    008219.00149
    Attorney Name
    Heather Smith-Carra
    Law Office Assigned Location Code
    N90
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
CUVUE ORPHALAN
Case File Statements
  • DM0000: The mark consists of the wording "CUVUE", in blue, stacked above the wording "ORPHALAN", in blue. Above the wording "CUVUE" appears a wavy band that is made up of individual brown and gold circles.
  • GS0051: Pharmaceutical preparations for the treatment of Wilson's disease; pharmaceutical products for the treatment of Wilson's disease; chemical preparations for medical purposes, namely, for treatment of Wilson's disease; chemical preparations for pharmaceutical purposes, namely, for treatment of Wilson's disease; medicinal substances, namely, therapeutic medication for the treatment of Wilson's disease; medicinal preparations for the treatment of Wilson's disease; chemical preparations for medical or pharmaceutical use for the treatment of Wilson's disease; pharmaceutical products and medicines for the treatment of Wilson's disease; pharmaceutical preparations for the diagnosis of Wilson disease; pharmaceutical and chemical preparations for medical purposes, namely, for copper level measurement for the diagnosis and treatment of Wilson's disease; chemical reagents for medical purposes; chemical reagents for medical diagnostic purposes in patients with Wilson's disease; pre-filled syringes sold filled with pharmaceuticals for medical purposes for the diagnosis and treatment of Wilson's disease; medicated serums for diagnostic purposes, specifically, for the treatment of Wilson's disease; biological preparations for medical purposes for the treatment of Wilson's disease, specifically, for the measurement of copper in patients with Wilson's disease; chemical preparations for medical purposes for the measurement of copper in patients with Wilson's disease; clinical diagnostic reagents for medical use; diagnostic preparations for medical purposes for treatment of Wilson's disease; medical diagnostic reagents and assays for testing of body fluids to diagnose the level of copper
  • CC0000: The color(s) blue, brown, and gold is/are claimed as a feature of the mark.
  • GS0441: Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the treatment of persons, namely diagnosis of copper levels in patients with Wilson's disease; medical screening; health care for patients with Wilson's disease; health assessment services care for patients with Wilson's disease; home-visit nursing care; medical services, namely, blood testing services provided by medical laboratories for patients with Wilson's disease; medical clinic services and medical analysis services provided by medical laboratories for diagnostic purposes for patients with Wilson's disease; medical analysis services provided by medical laboratories for diagnostic purposes to measure copper levels in patients with Wilson's disease; medical diagnostic testing, monitoring and reporting services for patients with Wilson's disease; medical testing for diagnostic or treatment purposes in the field of Wilson's disease
Case File Event Statements
  • 4/25/2023 - a year ago
    25 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 4/5/2023 - a year ago
    24 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 4/5/2023 - a year ago
    23 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 3/20/2023 - a year ago
    22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/20/2022 - a year ago
    21 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/20/2022 - a year ago
    20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/4/2022 - 2 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/4/2022 - 2 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/3/2022 - 2 years ago
    17 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 9/14/2022 - 2 years ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/14/2022 - 2 years ago
    15 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 9/14/2022 - 2 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/26/2022 - 2 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/25/2022 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/25/2022 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/25/2022 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/23/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/4/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/4/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/19/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/18/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/8/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/29/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/25/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/24/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR